Oupushifang Pharmaceutical Technology Co., Ltd.
Quick facts
Phase 3 pipeline
- Atropine sulfate eye drops 0.01% · Ophthalmology
Atropine is a muscarinic acetylcholine receptor antagonist that blocks parasympathetic signaling in the eye to inhibit accommodation and pupil constriction. - Atropine sulfate eye drops 0.02% · Ophthalmology
Atropine blocks muscarinic acetylcholine receptors in the eye to dilate the pupil and paralyze accommodation, slowing myopia progression in children.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: